Finally, to verify our findings in human HER2+-BC samples, we performed GSEA analyses on publically available mRNA-seq data from The Cancer Genome Atlas (TCGA; https://portal.gdc.cancer.gov/) stratifying patients based on RNF40 expression. This evidence concerns the gene ERBB2 and breast cancer.